| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.2 |